Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

TearLab Corporation

TRADE

NASDAQ: TEARHealthcare / Medical Laboratories & Research / USA
0.106+0.001+0.95%Vol 57 4401Y Perf -92.21%
Oct 16th, 2018 15:38
BID0.00 ASK0.00
Open0.106 Previous Close0.105
Pre-Market- After-Trading-
 - -%  - -%
Target Price
3.50 
Analyst Rating
— 0.00
Potencial %
3 201.89 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★+     47.71
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)1 
Earnings Rating
Neutral
Price Range Ratio 52wk %
0.43 
Earnings Date
12th Nov 2018

Today's Price Range

0.1050.106

 

52wk Range

0.101.49

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-40.45%
3 Months
-37.65%
6 Months
-57.60%
1 Year
-92.21%
3 Years
-99.45%
5 Years
-99.90%

Quotes

Name / TickerPriceChg.Chg.%
TEAR0.1060.00100.95
AAPL222.154.79002.20
GOOG1 121.2829.03002.66
MSFT111.003.40003.16
XOM81.200.38000.47
WFC53.730.49000.92
JNJ136.562.61001.95
FB158.785.26003.43
GE12.10-0.0500-0.41
JPM108.622.28002.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.80
Current Ratio 1.00
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -7.40
Leverage Ratio -0.60
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin55.40
EBIT Margin-18.40
EBITDA Margin-12.30
Pre-tax Profit Margin-116.20
Profit Margin-27.91
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 8.11
PS Ratios 0.07
Price to Cash Flow -
Price to Free Cash Flow -0.50
Cash Flow Per Share -0.59
Price to Tangible Book-0.07
Book Value per Share-1.86
Enterprise Value (in ths.)24 588
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-226.16
ROE last 12 Months 55.70
Return on Assets (5Y Avg) -150.16
ROA last 12 Months -57.43
Return on Capital (5Y Avg) -
ROC last 12 Months -
Return on invested Capital Q -
Return on invested Capital Y-
Assets Turnover0.40
Receivables Turnover4.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)19 740
Revenue per Share 1.83
Revenue Growth 3 Years -1.75
Revenue Growth 5 Years 13.18
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018--0.06-
Q01 2018-0.37-0.0975.68
Q04 2017--0.55-
Q03 2017-0.73-0.678.22
Q02 2017-0.75-0.689.33
Q01 2017-0.75-0.82-9.33
Q04 2016-0.90-0.8110.00
Q03 2016-0.80-0.7012.50
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.360.00-
9/2018 QR-0.330.00-
12/2018 FY-1.360.00-
12/2018 FY-1.3620.00Positive
Next Report Date12th Nov 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume57 440
Shares Outstanding (in ths.)11 300
Trades Count9
Dollar Volume3 553
Avg. Volume73 379
Avg. Weekly Volume161 964
Avg. Monthly Volume60 571
Avg. Quarterly Volume57 166

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

78%22%

Bearish Bullish

55%45%

Bearish Bullish

59%41%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News

x